Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TTD vs MRNA✓SelectedUSD · MRNATTD vs MRNA performance historyLatest closeAs of-8.10%11/20
Stock and ETF performance explorer

TTD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-87.0%
MRNA return
-27.3%
Excess return
-59.8%
Maximum drawdown
-91.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.1%-2.2%-5.9%-7.9%
7D-14.7%-12.7%-2.0%-13.6%
30D+6.3%-20.7%+26.9%+8.2%
3M+0.5%+46.3%-45.8%-3.9%
6M-36.3%+305.2%-341.6%-52.2%
YTD-64.8%+561.2%-626.0%-77.6%
1Y-65.1%+772.1%-837.2%-79.7%
3Y-80.1%+147.0%-227.1%-85.4%
All-87.0%-27.3%-59.8%-87.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling